Portfolio Companies

  • AI/ML Ops
    Architecture, Engineering, and Construction
    B2B GTM
    B2C MarTech & Customer Support
    BioTech/Therapeutics
    Consumer
    Cybersecurity
    Data & Data Mgmt.
    DevOps
    eCommerce Enablement
    Education
    Energy & Climate
    Finance & Accounting
    Financial Services
    Gaming
    Government
    Healthcare
    Human Capital
    IT Mgmt
    Legal & Compliance
    Manufacturing
    Marketplace
    Other Vertical Market SaaS
    Payments
    Product & Process Management
    Real Estate
    Supply Chain & Logistics
    Web3
  • North America
    Africa
    Western Europe
    Eastern Europe
    Asia Pacific
    Israel
    South America
  • Current Investment
    Prior Investment

Limerick, No Data Available, Ireland

Amsterdam, No Data Available, Netherlands

Tel Aviv, No Data Available, Israel

Bonn, No Data Available, Germany

Miami, Florida, U.S.

San Francisco, California, U.S.

Insight Partners is an awesome firm that shares many of our values, and we’ve been grateful to have them as partners on this journey of building a great company based on a great product.
Eran Zinman
Co-Founder & CEO Monday.com*

London, No Data Available, U.K.

Lehi, Utah, U.S.

Farmington, Utah, U.S.

Espressive logo

San Francisco, California, U.S.

Wilmington, North Carolina, U.S.

San Francisco, California, U.S.

BrightInsight provides the leading global regulated digital health platform for biopharma and medtech. Every line of code of our BrightInsight Platform is built under a Quality Management System to support and optimize regulated drugs, devices and software through integrated data and actionable insights. The Platform can enable our customers to drive increased patient adherence and engagement across therapeutic areas, with active projects in diabetes, respiratory, oncology, ophthalmology, obesity, hematology, immunology, neurology and more. The BrightInsight™ Platform uses software and services to capture, transmit and analyze data from CE-marked and FDA-regulated medical devices, combination products, apps and Software as a Medical Device, in compliance with global security, privacy and regulatory requirements. Deployed as a managed service, the platform accelerates time to market for biopharma and medtech companies, reduces the cost of implementation and maintenance versus a custom solution, and scales across products and global markets. 

Investment Team Peter Sobiloff Jeff Horing
Sectors Healthcare Pharma
Initial Investment June 2020
Status Current Investment